Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

32 in total

1. Encapsulated papillary thyroid carcinoma: is it a distinctive clinical entity with low-grade malignancy?

Authors: A Pisanu; D Deplano; I Reccia; G Porceddu; A Uccheddu
Journal: J Endocrinol Invest Date: 2012-01-31 Impact factor: 4.256

2. Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.

Authors: Frederik A Verburg; Cumali Aktolun; Arturo Chiti; Savvas Frangos; Luca Giovanella; Martha Hoffmann; Ioannis Iakovou; Jasna Mihailovic; Bernd J Krause; Werner Langsteger; Markus Luster
Journal: Eur J Nucl Med Mol Imaging Date: 2016-02-17 Impact factor: 9.236

3. The relationship between thyroid volume and malignant thyroid disease.

Authors: Ayse Ocak Duran; Cuneyd Anil; Alptekin Gursoy; Aslı Nar; Ozden Altundag; Mevlude Inanc; Oktay Bozkurt; Neslihan Bascil Tutuncu
Journal: Med Oncol Date: 2013-12-12 Impact factor: 3.064

4. One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.

Authors: Markus Dietlein; F A Verburg; M Luster; C Reiners; F Pitoia; H Schicha
Journal: Eur J Nucl Med Mol Imaging Date: 2011-05 Impact factor: 9.236

Review 5. The role of nuclear medicine in differentiated thyroid cancer.

Authors: Susanne Kohlfürst
Journal: Wien Med Wochenschr Date: 2012-07-20

Review 6. Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors: Markus Luster; Theresia Weber; Frederik A Verburg
Journal: Nat Rev Endocrinol Date: 2014-07-01 Impact factor: 43.330

Review 7. Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

Authors: Nicholas S Andresen; John M Buatti; Hamed H Tewfik; Nitin A Pagedar; Carryn M Anderson; John M Watkins
Journal: Eur Thyroid J Date: 2017-03-23

Review 8. [Surgical therapy for thyroid gland malignancies].

Authors: P E Goretzki; K Schwarz; B Lammers
Journal: HNO Date: 2013-01 Impact factor: 1.284

9. Endogenous TSH levels at the time of ¹³¹I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.

Authors: Alexis Vrachimis; Burkhard Riemann; Uwe Mäder; Christoph Reiners; Frederik A Verburg
Journal: Eur J Nucl Med Mol Imaging Date: 2015-10-23 Impact factor: 9.236

10. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

Authors: Bruno Niederle; Frédéric Sebag; Michael Brauckhoff
Journal: Langenbecks Arch Surg Date: 2013-12-03 Impact factor: 3.445

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.